Astressin-B is a nonselective corticotropin releasing hormone antagonist that reduces the synthesis of ACTH and cortisol

Reducing ACTH synthesis, it improves the sexual drive of rats under stressing conditions.

In 2011, research showed that treatment with astressin-B caused the sudden growth of hair in mice bred for a propensity for stress.

Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk.